Cameco (TSE:CCO – Free Report) (NYSE:CCJ) had its target price increased by Bank of America from C$93.00 to C$106.00 in a report published on Tuesday morning,BayStreet.CA reports.
Other equities analysts have also issued research reports about the stock. BMO Capital Markets lifted their price target on shares of Cameco from C$85.00 to C$95.00 and gave the stock an “outperform” rating in a report on Monday. Sanford C. Bernstein upgraded shares of Cameco to a “strong-buy” rating in a report on Tuesday, April 1st. Scotiabank lifted their target price on Cameco from C$88.00 to C$93.00 and gave the stock an “outperform” rating in a report on Monday. National Bankshares lifted their target price on Cameco from C$81.00 to C$95.00 in a report on Monday. Finally, Desjardins raised Cameco to a “moderate buy” rating in a research note on Thursday, April 3rd. Eight equities research analysts have rated the stock with a buy rating and five have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cameco currently has a consensus rating of “Buy” and an average price target of C$92.92.
Get Our Latest Stock Report on CCO
Cameco Stock Down 0.7%
Cameco Company Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
See Also
- Five stocks we like better than Cameco
- Technology Stocks Explained: Here’s What to Know About Tech
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks Set to Double—And There’s Still Time to Buy
- What is a Secondary Public Offering? What Investors Need to Know
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.